Influence of postoperative complications on long-term outcome after oncologic lung resection surgery. Substudy of a randomized control trial
Lung resection surgery (LRS) causes an intense local and systemic inflammatory response. There is a relationship between inflammation and postoperative complications (POCs). Also, it has been proposed that the inflammation and complications related with the surgery may promote the recurrence of canc...
Gespeichert in:
Veröffentlicht in: | Journal of clinical monitoring and computing 2021-10, Vol.35 (5), p.1183-1192 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1192 |
---|---|
container_issue | 5 |
container_start_page | 1183 |
container_title | Journal of clinical monitoring and computing |
container_volume | 35 |
creator | Casanova Barea, Javier De la Gala, Francisco Piñeiro, Patricia Reyes, Almudena Simón, Carlos Rancan, Lisa Vara, Elena Paredes, Sergio Bellón, Jose María Garutti Martinez, Ignacio |
description | Lung resection surgery (LRS) causes an intense local and systemic inflammatory response. There is a relationship between inflammation and postoperative complications (POCs). Also, it has been proposed that the inflammation and complications related with the surgery may promote the recurrence of cancer and therefore deterioration of survival. We investigated the association between inflammatory biomarkers, severity of POCs and long-term outcome in patients who were discharged after LRS. This is a prospective substudy of a randomized control trial. We established three groups based in the presence of POCs evaluated by Clavien-Dindo (C-D) classification: Patients with no postoperative complications (No-POCs group) (C-D = 0), patients who developed light POCs (L-POCs group) (C-D = I-II), and major POCs (M-POCs group) (C-D = III, IV, or V). Kaplan–Meier curves and Cox regression model were created to compare survival and oncologic recurrence in those groups. Patients who developed POCs (light or major) had an increase in some inflammatory biomarkers (TNF-α, IL-6, IL-7, IL-8) compared with No-POCs group. This pro-inflammatory status plays a fundamental role in the appearance of POCs and therefore in a shorter life expectancy. Individuals in the M-POCs group had a higher risk of death (HR = 3.59, 95% CI 1.69 to 7.63) compared to individuals in the No-POCs group (p = 0.001). Patients of L-POCs group showed better survival than M-POCs group (HR = 2.16, 95% CI 1.00 to 4.65, p = 0.049). Besides, M-POCs patients had higher risk of recurrence in the first 2 years, when compared with L-POCs (p = 0,008) or with No-POCs (p = 0.002). In patients who are discharged after undergoing oncologic LRS, there is an association between POCs occurrence and long term outcome. Oncologist should pay special attention in patients who develop POCs after LRS. |
doi_str_mv | 10.1007/s10877-020-00580-1 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2434481685</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2434481685</sourcerecordid><originalsourceid>FETCH-LOGICAL-c418t-93f8c4e2d01d5028027be505738a4203d45fe2b3fb224806f5b93718ba98efd53</originalsourceid><addsrcrecordid>eNp9kcuKFTEQhhtRcBx9AVcBN24yVi59kl7K4GVgwIW6Dul05dBDOmlzEY7P4EOb4xEEF66Sor6_bv8wvGRwwwDUm8JAK0WBAwUYNVD2aLhioxKUH5h83P9CK8oEqKfDs1IeAGDSgl0NP--iDw2jQ5I82VOpacds6_odiUvbHlbXgxQLSZGEFI-0Yt5IarVnkVjfw55yKaTj6kho8UgyFnRnESktHzGfbsjnNpfaltO5iSXZxiVt6w9ceo9Ycwqk5tWG58MTb0PBF3_e6-Hr-3dfbj_S-08f7m7f3lMnma50El47iXwBtozANXA14wh9W20lB7HI0SOfhZ85lxoOfpwnoZie7aTRL6O4Hl5f6u45fWtYqtnW4jAEGzG1YrgUUmp20Gf01T_oQ2o59ukMH9WkleAH6BS_UC6nUjJ6s-d1s_lkGJizQeZikOkGmd8GGdZF4iIqHY79Tn9L_0f1C07xlcU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2579873260</pqid></control><display><type>article</type><title>Influence of postoperative complications on long-term outcome after oncologic lung resection surgery. Substudy of a randomized control trial</title><source>Springer journals</source><creator>Casanova Barea, Javier ; De la Gala, Francisco ; Piñeiro, Patricia ; Reyes, Almudena ; Simón, Carlos ; Rancan, Lisa ; Vara, Elena ; Paredes, Sergio ; Bellón, Jose María ; Garutti Martinez, Ignacio</creator><creatorcontrib>Casanova Barea, Javier ; De la Gala, Francisco ; Piñeiro, Patricia ; Reyes, Almudena ; Simón, Carlos ; Rancan, Lisa ; Vara, Elena ; Paredes, Sergio ; Bellón, Jose María ; Garutti Martinez, Ignacio</creatorcontrib><description>Lung resection surgery (LRS) causes an intense local and systemic inflammatory response. There is a relationship between inflammation and postoperative complications (POCs). Also, it has been proposed that the inflammation and complications related with the surgery may promote the recurrence of cancer and therefore deterioration of survival. We investigated the association between inflammatory biomarkers, severity of POCs and long-term outcome in patients who were discharged after LRS. This is a prospective substudy of a randomized control trial. We established three groups based in the presence of POCs evaluated by Clavien-Dindo (C-D) classification: Patients with no postoperative complications (No-POCs group) (C-D = 0), patients who developed light POCs (L-POCs group) (C-D = I-II), and major POCs (M-POCs group) (C-D = III, IV, or V). Kaplan–Meier curves and Cox regression model were created to compare survival and oncologic recurrence in those groups. Patients who developed POCs (light or major) had an increase in some inflammatory biomarkers (TNF-α, IL-6, IL-7, IL-8) compared with No-POCs group. This pro-inflammatory status plays a fundamental role in the appearance of POCs and therefore in a shorter life expectancy. Individuals in the M-POCs group had a higher risk of death (HR = 3.59, 95% CI 1.69 to 7.63) compared to individuals in the No-POCs group (p = 0.001). Patients of L-POCs group showed better survival than M-POCs group (HR = 2.16, 95% CI 1.00 to 4.65, p = 0.049). Besides, M-POCs patients had higher risk of recurrence in the first 2 years, when compared with L-POCs (p = 0,008) or with No-POCs (p = 0.002). In patients who are discharged after undergoing oncologic LRS, there is an association between POCs occurrence and long term outcome. Oncologist should pay special attention in patients who develop POCs after LRS.</description><identifier>ISSN: 1387-1307</identifier><identifier>EISSN: 1573-2614</identifier><identifier>DOI: 10.1007/s10877-020-00580-1</identifier><language>eng</language><publisher>Dordrecht: Springer Netherlands</publisher><subject>Anesthesiology ; Biomarkers ; Critical Care Medicine ; Health Sciences ; Inflammatory response ; Intensive ; Life expectancy ; Lungs ; Medicine ; Medicine & Public Health ; Original Research ; Regression models ; Statistics for Life Sciences ; Surgery ; Survival</subject><ispartof>Journal of clinical monitoring and computing, 2021-10, Vol.35 (5), p.1183-1192</ispartof><rights>Springer Nature B.V. 2020</rights><rights>Springer Nature B.V. 2020.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c418t-93f8c4e2d01d5028027be505738a4203d45fe2b3fb224806f5b93718ba98efd53</citedby><cites>FETCH-LOGICAL-c418t-93f8c4e2d01d5028027be505738a4203d45fe2b3fb224806f5b93718ba98efd53</cites><orcidid>0000-0002-2334-7475</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s10877-020-00580-1$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s10877-020-00580-1$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27903,27904,41467,42536,51297</link.rule.ids></links><search><creatorcontrib>Casanova Barea, Javier</creatorcontrib><creatorcontrib>De la Gala, Francisco</creatorcontrib><creatorcontrib>Piñeiro, Patricia</creatorcontrib><creatorcontrib>Reyes, Almudena</creatorcontrib><creatorcontrib>Simón, Carlos</creatorcontrib><creatorcontrib>Rancan, Lisa</creatorcontrib><creatorcontrib>Vara, Elena</creatorcontrib><creatorcontrib>Paredes, Sergio</creatorcontrib><creatorcontrib>Bellón, Jose María</creatorcontrib><creatorcontrib>Garutti Martinez, Ignacio</creatorcontrib><title>Influence of postoperative complications on long-term outcome after oncologic lung resection surgery. Substudy of a randomized control trial</title><title>Journal of clinical monitoring and computing</title><addtitle>J Clin Monit Comput</addtitle><description>Lung resection surgery (LRS) causes an intense local and systemic inflammatory response. There is a relationship between inflammation and postoperative complications (POCs). Also, it has been proposed that the inflammation and complications related with the surgery may promote the recurrence of cancer and therefore deterioration of survival. We investigated the association between inflammatory biomarkers, severity of POCs and long-term outcome in patients who were discharged after LRS. This is a prospective substudy of a randomized control trial. We established three groups based in the presence of POCs evaluated by Clavien-Dindo (C-D) classification: Patients with no postoperative complications (No-POCs group) (C-D = 0), patients who developed light POCs (L-POCs group) (C-D = I-II), and major POCs (M-POCs group) (C-D = III, IV, or V). Kaplan–Meier curves and Cox regression model were created to compare survival and oncologic recurrence in those groups. Patients who developed POCs (light or major) had an increase in some inflammatory biomarkers (TNF-α, IL-6, IL-7, IL-8) compared with No-POCs group. This pro-inflammatory status plays a fundamental role in the appearance of POCs and therefore in a shorter life expectancy. Individuals in the M-POCs group had a higher risk of death (HR = 3.59, 95% CI 1.69 to 7.63) compared to individuals in the No-POCs group (p = 0.001). Patients of L-POCs group showed better survival than M-POCs group (HR = 2.16, 95% CI 1.00 to 4.65, p = 0.049). Besides, M-POCs patients had higher risk of recurrence in the first 2 years, when compared with L-POCs (p = 0,008) or with No-POCs (p = 0.002). In patients who are discharged after undergoing oncologic LRS, there is an association between POCs occurrence and long term outcome. Oncologist should pay special attention in patients who develop POCs after LRS.</description><subject>Anesthesiology</subject><subject>Biomarkers</subject><subject>Critical Care Medicine</subject><subject>Health Sciences</subject><subject>Inflammatory response</subject><subject>Intensive</subject><subject>Life expectancy</subject><subject>Lungs</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Original Research</subject><subject>Regression models</subject><subject>Statistics for Life Sciences</subject><subject>Surgery</subject><subject>Survival</subject><issn>1387-1307</issn><issn>1573-2614</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp9kcuKFTEQhhtRcBx9AVcBN24yVi59kl7K4GVgwIW6Dul05dBDOmlzEY7P4EOb4xEEF66Sor6_bv8wvGRwwwDUm8JAK0WBAwUYNVD2aLhioxKUH5h83P9CK8oEqKfDs1IeAGDSgl0NP--iDw2jQ5I82VOpacds6_odiUvbHlbXgxQLSZGEFI-0Yt5IarVnkVjfw55yKaTj6kho8UgyFnRnESktHzGfbsjnNpfaltO5iSXZxiVt6w9ceo9Ycwqk5tWG58MTb0PBF3_e6-Hr-3dfbj_S-08f7m7f3lMnma50El47iXwBtozANXA14wh9W20lB7HI0SOfhZ85lxoOfpwnoZie7aTRL6O4Hl5f6u45fWtYqtnW4jAEGzG1YrgUUmp20Gf01T_oQ2o59ukMH9WkleAH6BS_UC6nUjJ6s-d1s_lkGJizQeZikOkGmd8GGdZF4iIqHY79Tn9L_0f1C07xlcU</recordid><startdate>20211001</startdate><enddate>20211001</enddate><creator>Casanova Barea, Javier</creator><creator>De la Gala, Francisco</creator><creator>Piñeiro, Patricia</creator><creator>Reyes, Almudena</creator><creator>Simón, Carlos</creator><creator>Rancan, Lisa</creator><creator>Vara, Elena</creator><creator>Paredes, Sergio</creator><creator>Bellón, Jose María</creator><creator>Garutti Martinez, Ignacio</creator><general>Springer Netherlands</general><general>Springer Nature B.V</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7SC</scope><scope>7SP</scope><scope>7U5</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>JQ2</scope><scope>K7-</scope><scope>K9.</scope><scope>KB0</scope><scope>L7M</scope><scope>L~C</scope><scope>L~D</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-2334-7475</orcidid></search><sort><creationdate>20211001</creationdate><title>Influence of postoperative complications on long-term outcome after oncologic lung resection surgery. Substudy of a randomized control trial</title><author>Casanova Barea, Javier ; De la Gala, Francisco ; Piñeiro, Patricia ; Reyes, Almudena ; Simón, Carlos ; Rancan, Lisa ; Vara, Elena ; Paredes, Sergio ; Bellón, Jose María ; Garutti Martinez, Ignacio</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c418t-93f8c4e2d01d5028027be505738a4203d45fe2b3fb224806f5b93718ba98efd53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Anesthesiology</topic><topic>Biomarkers</topic><topic>Critical Care Medicine</topic><topic>Health Sciences</topic><topic>Inflammatory response</topic><topic>Intensive</topic><topic>Life expectancy</topic><topic>Lungs</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Original Research</topic><topic>Regression models</topic><topic>Statistics for Life Sciences</topic><topic>Surgery</topic><topic>Survival</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Casanova Barea, Javier</creatorcontrib><creatorcontrib>De la Gala, Francisco</creatorcontrib><creatorcontrib>Piñeiro, Patricia</creatorcontrib><creatorcontrib>Reyes, Almudena</creatorcontrib><creatorcontrib>Simón, Carlos</creatorcontrib><creatorcontrib>Rancan, Lisa</creatorcontrib><creatorcontrib>Vara, Elena</creatorcontrib><creatorcontrib>Paredes, Sergio</creatorcontrib><creatorcontrib>Bellón, Jose María</creatorcontrib><creatorcontrib>Garutti Martinez, Ignacio</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Nursing and Allied Health Journals</collection><collection>Computer and Information Systems Abstracts</collection><collection>Electronics & Communications Abstracts</collection><collection>Solid State and Superconductivity Abstracts</collection><collection>Health Medical collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies & Aerospace Collection</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Computer Science Collection</collection><collection>Computer Science Database</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Advanced Technologies Database with Aerospace</collection><collection>Computer and Information Systems Abstracts Academic</collection><collection>Computer and Information Systems Abstracts Professional</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest advanced technologies & aerospace journals</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of clinical monitoring and computing</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Casanova Barea, Javier</au><au>De la Gala, Francisco</au><au>Piñeiro, Patricia</au><au>Reyes, Almudena</au><au>Simón, Carlos</au><au>Rancan, Lisa</au><au>Vara, Elena</au><au>Paredes, Sergio</au><au>Bellón, Jose María</au><au>Garutti Martinez, Ignacio</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Influence of postoperative complications on long-term outcome after oncologic lung resection surgery. Substudy of a randomized control trial</atitle><jtitle>Journal of clinical monitoring and computing</jtitle><stitle>J Clin Monit Comput</stitle><date>2021-10-01</date><risdate>2021</risdate><volume>35</volume><issue>5</issue><spage>1183</spage><epage>1192</epage><pages>1183-1192</pages><issn>1387-1307</issn><eissn>1573-2614</eissn><abstract>Lung resection surgery (LRS) causes an intense local and systemic inflammatory response. There is a relationship between inflammation and postoperative complications (POCs). Also, it has been proposed that the inflammation and complications related with the surgery may promote the recurrence of cancer and therefore deterioration of survival. We investigated the association between inflammatory biomarkers, severity of POCs and long-term outcome in patients who were discharged after LRS. This is a prospective substudy of a randomized control trial. We established three groups based in the presence of POCs evaluated by Clavien-Dindo (C-D) classification: Patients with no postoperative complications (No-POCs group) (C-D = 0), patients who developed light POCs (L-POCs group) (C-D = I-II), and major POCs (M-POCs group) (C-D = III, IV, or V). Kaplan–Meier curves and Cox regression model were created to compare survival and oncologic recurrence in those groups. Patients who developed POCs (light or major) had an increase in some inflammatory biomarkers (TNF-α, IL-6, IL-7, IL-8) compared with No-POCs group. This pro-inflammatory status plays a fundamental role in the appearance of POCs and therefore in a shorter life expectancy. Individuals in the M-POCs group had a higher risk of death (HR = 3.59, 95% CI 1.69 to 7.63) compared to individuals in the No-POCs group (p = 0.001). Patients of L-POCs group showed better survival than M-POCs group (HR = 2.16, 95% CI 1.00 to 4.65, p = 0.049). Besides, M-POCs patients had higher risk of recurrence in the first 2 years, when compared with L-POCs (p = 0,008) or with No-POCs (p = 0.002). In patients who are discharged after undergoing oncologic LRS, there is an association between POCs occurrence and long term outcome. Oncologist should pay special attention in patients who develop POCs after LRS.</abstract><cop>Dordrecht</cop><pub>Springer Netherlands</pub><doi>10.1007/s10877-020-00580-1</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0002-2334-7475</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1387-1307 |
ispartof | Journal of clinical monitoring and computing, 2021-10, Vol.35 (5), p.1183-1192 |
issn | 1387-1307 1573-2614 |
language | eng |
recordid | cdi_proquest_miscellaneous_2434481685 |
source | Springer journals |
subjects | Anesthesiology Biomarkers Critical Care Medicine Health Sciences Inflammatory response Intensive Life expectancy Lungs Medicine Medicine & Public Health Original Research Regression models Statistics for Life Sciences Surgery Survival |
title | Influence of postoperative complications on long-term outcome after oncologic lung resection surgery. Substudy of a randomized control trial |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T17%3A18%3A54IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Influence%20of%20postoperative%20complications%20on%20long-term%20outcome%20after%20oncologic%20lung%20resection%20surgery.%20Substudy%20of%20a%20randomized%20control%20trial&rft.jtitle=Journal%20of%20clinical%20monitoring%20and%20computing&rft.au=Casanova%20Barea,%20Javier&rft.date=2021-10-01&rft.volume=35&rft.issue=5&rft.spage=1183&rft.epage=1192&rft.pages=1183-1192&rft.issn=1387-1307&rft.eissn=1573-2614&rft_id=info:doi/10.1007/s10877-020-00580-1&rft_dat=%3Cproquest_cross%3E2434481685%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2579873260&rft_id=info:pmid/&rfr_iscdi=true |